Life science product company Bio-Rad Laboratories has launched the PTC Harmony Thermal Cycler line. The line is designed to ...

Q1 2026 earnings call recap: guidance cut on Middle East headwinds, ddPCR/QX700 momentum, margins & FCF outlook—read key takeaways.

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, today announced the ...

First-year students enrolled in principles of biology at Commonwealth University-Lock Haven recently participated in a hands-on laboratory experience using real-time Polymerase Chain Reaction (PCR) ...

Bio-Rad Laboratories shares fell as the company faces margin pressure related to declining academic research funding. The stock slipped 10.6% to $261.43 Friday. Shares are down 14% over the past 12 ...

Chief Executive Officer — Norman Schwartz President and Chief Operating Officer — Jonathan DiVincenzo Executive Vice President and Chief Financial Officer — Roop Lakkaraju Yong Chung: Good afternoon, ...

Abstract: This is a proof-of-concept study for the development of a field-deployable and low-cost PCR thermocycler (FLC-PCR) to perform Polymerase Chain Reaction (PCR) for the rapid detection of ...

Dermatology is entering a "biological revolution," with engineered tissues and bio-machines offering new therapeutic possibilities. Photobiomodulation (PBM) is emerging as a promising therapy, acting ...

As next-generation sequencing (NGS) moves deeper into clinical research, population-scale programs, and AI-driven discovery, a new bottleneck has become impossible to ignore: sample prep. For Pranav ...

The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low. Bio-Rad's Q3 saw the company book ...